Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ormat Technologies | ORA | Jan 31, 2025 | 64.15 | -0.16 |
Orrstown Financial Services | ORRF | Jan 31, 2025 | 36.34 | -0.74 |
Orthofix Medical | OFIX | Jan 31, 2025 | 18.33 | -1.72 |
OrthoPediatrics | KIDS | Jan 31, 2025 | 24.00 | -0.58 |
Oruka Therapeutics | ORKA | Jan 31, 2025 | 13.45 | +6.16 |
OS Therapies | OSTX | Jan 31, 2025 | 1.84 | -5.64 |
Oscar Health A | OSCR | Jan 31, 2025 | 16.60 | -4.05 |
Oshkosh | OSK | Jan 31, 2025 | 116.40 | +2.77 |
OSI Systems | OSIS | Jan 31, 2025 | 196.44 | +0.12 |
Osisko Development | ODV | Jan 31, 2025 | 1.57 | -2.48 |
Osisko Gold Royalties | OR | Jan 31, 2025 | 18.52 | -0.48 |
Ostin Technology Group | OST | Jan 31, 2025 | 2.57 | 0.00 |
Otis Worldwide | OTIS | Jan 31, 2025 | 95.42 | +0.06 |
Otter Tail | OTTR | Jan 31, 2025 | 77.04 | -0.82 |
Ouster | OUST | Jan 31, 2025 | 9.96 | +0.81 |
Outbrain | OB | Jan 31, 2025 | 6.01 | -1.48 |
Outfront Media | OUT | Jan 31, 2025 | 18.40 | -0.43 |
Outlook Therapeutics | OTLK | Jan 31, 2025 | 2.06 | +1.98 |
Outset Medical | OM | Jan 31, 2025 | 0.80 | -1.48 |
Ovid Therapeutics | OVID | Jan 31, 2025 | 0.66 | -5.24 |
Ovintiv | OVV | Jan 31, 2025 | 42.22 | -3.76 |
Owens & Minor | OMI | Jan 31, 2025 | 14.24 | -2.47 |
Owens Corning | OC | Jan 31, 2025 | 184.55 | -3.29 |
Owlet A | OWLT | Jan 31, 2025 | 4.46 | -3.04 |
Oxbridge Re | OXBR | Jan 31, 2025 | 4.27 | -6.15 |
Oxford Industries | OXM | Jan 31, 2025 | 83.86 | -2.82 |
Oxford Lane Capital | OXLC | Jan 31, 2025 | 5.10 | +0.20 |
Oxford Lane Capital 2027 Pref | OXLCP | Jan 31, 2025 | 24.18 | +0.07 |
Oxford Square Capital | OXSQ | Jan 31, 2025 | 2.71 | +1.50 |
P10 | PX | Jan 31, 2025 | 13.66 | -0.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.